Fig. 5From: Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumabA-C. IoD, CS, and baseline CEA differences between the R + and R − groups at 6-RECIST v1.1. D. AUC of IoD, CS, and baseline CEA in R + and R − groupsBack to article page